Stock-Based Compensation; Changes in Equity (Details 1) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares Outstanding at the end of period (in shares)	148,000
Shares, Exercisable (in shares)	88,000
Weighted Average Exercise Price, Outstanding at the end of period (in dollars per share)	$ 5.22
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 5.20
Weighted Average Remaining Contractual Life, Outstanding (in years)	2 years 2 months 12 days
Weighted Average Remaining Contractual Life, Exercisable (in years)	1 year 6 months
Aggregate Intrinsic Value Outstanding (in dollars)	$ 172,850
Aggregate Intrinsic Value, Exercisable (in dollars)	$ 104,658
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares Outstanding, beginning of period (in shares)	140,048
Shares, Granted (in shares)	76,675
Shares Outstanding at the end of period (in shares)	216,723	140,048
Shares, Exercisable (in shares)	0
Weighted Average Exercise Price, Outstanding, beginning of period (in dollars per share)	$ 0.01
Weighted Average Exercise Price, Granted (in dollars per share)	7.00
Weighted Average Exercise Price, Outstanding at the end of period (in dollars per share)	2.48	$ 0.01
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 0
Weighted Average Remaining Contractual Life, Outstanding (in years)	4 years 9 months	6 years 6 months 18 days
Weighted Average Remaining Contractual Life, Granted (in years)	2 years 9 months 18 days
Weighted Average Remaining Contractual Life, Exercisable (in years)	0 years
Aggregate Intrinsic Value Outstanding (in dollars)	$ 893,506	$ 714,245
Aggregate Intrinsic Value, Granted (in dollars)		$ 0
Aggregate Intrinsic Value, Exercisable (in dollars)	$ 0